LGND AI, Inc. | $9,000,000 | (Jul 11, 2025)
Cerebrium | $8,500,000 | (Jul 11, 2025)
Bilt | $250,000,000 | (Jul 11, 2025)
Certified by Founder
Lodge
PAQ Therapeutics
start up
United States
- Burlington, MA
- 08/05/2025
- Series B
- $39,000,000
PAQ Therapeutics is a biotechnology company pioneering a new approach to restoring heath and curing disease through autophagy, the body’s most versatile mechanism for natural cellular degradation. With our ATTEC (autophagosome-tethering compound) technology, we are developing a novel class of small molecule degraders capable of binding a diverse array of substrates to the autophagy pathway including proteins, aggregates, lipids, organelles and pathogens. PAQ’s research advances in this important new class of degradation therapies have the potential to fundamentally transform drug discovery and development.
- Industry Biotechnology Research
- Website https://www.paqtx.com/
- LinkedIn https://www.linkedin.com/company/paq-therapeutics/
Aqtual, Inc. | $31,000,000 | (Jul 11, 2025)
Knox Systems, Inc. | $6,500,000 | (Jul 11, 2025)
Live Story | $3,154,279 | (Jul 11, 2025)
Spacelift | $51,000,000 | (Jul 11, 2025)
Foundation EGI | $23,000,000 | (Jul 11, 2025)
Augmentus Robotics | $11,000,000 | (Jul 11, 2025)
Datafy.io | $20,000,000 | (Jul 11, 2025)
Renasant Bio | $54,500,000 | (Jul 11, 2025)
Supply Wisdom | $14,000,000 | (Jul 10, 2025)